全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Multiple Myeloma: Modification and Adaptation of Plasma Cell Morphology Algorithm for the Prognosis of Congolese Patient

DOI: 10.4236/ojbd.2022.122003, PP. 29-38

Keywords: Plasma Cell Morphology Algorithm, Plasma Cell Types, Aberrant Plasma Cells, Immature Plasma Cells, Multiple Myeloma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objectives: To determine the multiple myeloma (MM) prognostic formulas applicable in Congolese with many aberrant and/or immature plasma cells according to GOASGUEN’s plasma cell morphology algorithm (PMA). Methods: The prospective, observational and descriptive study was carried out at the Ngaliema Clinic in Kinshasa from July 2016 to December 2019. The variables studied were the plasma cell types and the prognosis groups according to GOASGUEN and ZANDECKI. The nucleolus, the chromatin and the N/C ratio of 2 for each plasma cell encountered in multiple myeloma are examined in order by asking three successive questions as follows: 1) Is the nucleolus present? If yes, we denote 1; if not, note 0; 2) Is the chromatin thin? If yes, we score 1; if not we score 0; 3) The N/C ratio is greater than 6, if so, 1 is noted; if not, we note 0. We obtain a number with 3 successive digits preceded by the letter P for each plasma cell. Results: The overall rate of immature plasma cells and aberrant plasma cells in MM among Congolese was high at 26.6%. Their integration in the prognostic formulas showed for group A\" = 22 patients, group B\" = 5 patients and group C\" = 32 patients. Examination of plasma cell types in the deceased showed that 14/17 had a P001 plasma cell count ≥ 15%. Conclusion: The high rate of aberrant and/or immature plasma cells, the P001 plasma cell type at a rate ≥ 15%, found mostly in group C\" with poor prognosis, are responsible for the aggressive nature of MM in Congolese Blacks.

References

[1]  Mufuta, J.P., Gini, E.K., Kayembe, N.Z. and Goasguen, J.E. (December, 2014) Plasma Cell Morphology in Multiple Myeloma. Rwanda Medical Journal, 71, 9-12.
[2]  Goasguen, J.E., Zandecki, M., Mathiot, C., Scheiff, J., Bizet, M., Ly-Sunnaram, B., Grosbois, B., Monconduit, M., Michaux, J.-L. and Facon, T. (1999) Mature Plasma Cells as Indicator of Better Prognosis in Multiple Myeloma. New Methodology for the Assessment of Plasma Cell Morphology. Leukemia Research, 23, 1133-1140.
https://doi.org/10.1016/S0145-2126(99)00132-0
[3]  Fritz, E., Ludwig, H. and Kundi, M. (1984) Prognostic Relevance of Cellular Morphology in Multiple Myeloma. Blood, 63, 1072-1709.
https://doi.org/10.1182/blood.V63.5.1072.1072
[4]  Greipp, P.R., Raymond, N.M., Kyle, R.A. and O’Fallon, W.N. (1985) Multiple Myeloma: Significance of Plasmablastic Subtype in Morphological Classification. Blood, 65, 305-310. https://doi.org/10.1182/blood.V65.2.305.305
[5]  Koffi, K.G., Sanogo, I., Trazo, D., Toure, A.H., Tolo, A., N’guessan, K., Danho, N.C., Kouakou N. and Sangare A. (2000) Caractéristiques du myélome multiple du Noir africain, expérience de la Cote d’Ivoire. Médecine d’Afrique Noire, 47, 430-435.
[6]  Diallo, D.A., Cissoko, L.S., Cissoko, Y., Diallo, Y., et al. (2005) Epidémiologie actuelle des hémopathies malignes dans les services d’hématologie oncologie médicale et de médecine interne de l’hôpital du Point G, Bamako, Mali. Mali Médical, 1-8.
[7]  Vilela, MA. (2016) Recurrence of Multiple Myeloma Detected by Fundoscopy—Case Report. EC Ophthalmology, 4, 542-545.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133